Genelabs Technologies' Other Investors

Genelabs Technologies raised a round of funding on , . Investors include Merlin Nexus.

is discovering compounds that selectively inhibit replication of the hepatitis C virus, and advancing preclinical development of compounds from this hepatitis C virus drug discovery program, while als…

Articles about Genelabs Technologies' Other Investors: